Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Board Changes

31 Jul 2006 16:17

Ovoca Gold PLC31 July 2006 OVOCA GOLC PLC CHANGES TO THE OVOCA GOLD BOARD Monday 31 July 2006 Ovoca Gold Plc (AIM: OVG; IEX: OVX) wishes to announce the following boardchanges that were effective from 28 July 2006: Mr Rowan Maule has been appointed to the board of the Company. Mr. Maule iscurrently the Chief Operating Officer in the Company, focussing on thedevelopment of Ovoca's Goltsovoye silver deposit in eastern Russia. As a miningengineer, Mr Maule will bring additional technical skills to the board. Mr John O'Connor takes over the role of Chief Financial Officer. Mr O'Connor isa Chartered Accountant and has been with the Company since 1997. Mr Paul Smithwick, Mr. Harry Dobson and Mr. Danesh Varma have resigned from theboard. Commenting on the Board changes Ovoca Gold Chairman, Roger Turner, said, Following the acquisition of the Goltsovoye Project in Russia in June of thisyear, at which time Leonid Skoptsov, Mikhail Mogutov and Yuri Radchenko becameNon Executive Directors, Ovoca needed to strengthen the Executive of the Boardand I would like to welcome Rowan Maule as Chief Operating Officer and JohnO'Connor as Chief Financial Officer. Rowan is an experienced mining engineer andhas been working on Goltsovoye for the past 12 months. He is directlyresponsible for bringing the Goltsovoye mine into production. John O'Connor, inaddition to the role of Secretary, is now the full time Chief Financial Officerbased in the London office and responsible for the commercial and financialaffairs of Ovoca and it's subsidiaries in Kola, Magadan, and Sweden. I wouldlike to take this opportunity of thanking the outgoing Directors, Paul, Harryand Danesh, for their contributions to the Board over the past months and yearsand welcome Rowan and John to their new posts. Ovoca Gold Plc is an international exploration company quoted in London (OVG.L) and Dublin (OVX.IR), exploring for precious and base metals in Russia, Sweden and Ireland For further information please visit www.ovocagold.com or contact: Simon Beardsmore, Commercial Manager - Ovoca Gold Plc Nick Bias / Alex Buck - Buck Bias (UK PR)Tel: +44 (0)207 397 8159 Tel: +44 (0)7887 920 530 / +44 (0)7932 740 452Email: simon.beardsmore@ovocagold.com Email: nick@buckbias.com / alex@buckbias.com John Frain - Davy Richard Chase - Ambrian (AIM Broker)Tel: +353 (0)1 679 6363 +44 (0)207 776 6461Email: john.frain@davy.ie Email: richard.chase@ambrian.com Tom McCormack - Connexions (Ireland PR)Tel: +353 (0)86 245 4215 / +353 (0)1 230 3015Email: tommcc@indigo.ie 31 July, 2006 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation
28th Sep 20207:00 amRNSDeath of a Director
21st Sep 20207:00 amRNSInterim Results
14th Aug 202011:05 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSAnnual Report
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSAcquisition of Remaining Minority Interest in IVIX
7th Nov 201912:45 pmRNSAttendance at Bio-Europe Conference
16th Sep 20197:00 amRNSInterim Results
12th Sep 20197:00 amRNSFiling of Marketing Authorisation Application
28th Aug 20197:00 amRNSDirectorate Change
8th Aug 20194:14 pmRNSResult of AGM
8th Aug 20199:05 amRNSSecond Price Monitoring Extn
8th Aug 20199:00 amRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSAGM Statement
26th Jul 20197:00 amRNSDirectorate Change
25th Jul 20194:41 pmRNSSecond Price Monitoring Extn
25th Jul 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20197:00 amRNSUS and EU Clinical Development Plans
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSOperational Update & Additional Investment in IVIX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.